Tarsus Pharmaceuticals, Inc. (TARS) Earnings
NASDAQ·Healthcare·Biotechnology
$62.04
+1.83%
Mkt Cap $2.62B
Next Earnings
In 8 daysThu, May 7, 2026
EPS Estimate
-$0.29
4 analysts
Revenue Estimate
$153.94M
Last quarter: missed by -94.17% on EPS, +4.91% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$2.62B
P/E
—
Fwd P/E
—
P/S
5.79
Rev TTM
—
EPS TTM
-$1.62